Anthropic places a flagship bet on AI for science
At the end of June, Anthropic launched Claude Science, a standalone product designed to support scientific research in the same way Claude Code supports software engineering.
- Published
- 24 July 2026
- Reading time
- 1 min
- Topics
- AI, Consumer Health, Leadership
- Written by
Bloom Partners Team
At the end of June, Anthropic launched Claude Science, a standalone product designed to support scientific research in the same way Claude Code supports software engineering. As MIT Technology Review reports, the platform allows researchers to run complex life sciences workflows through natural language, with direct integration into high-performance computing environments. Anthropic is also using the tool to pursue its own research into drug candidates for neglected diseases, positioning itself to take up the scientific mantle that Google DeepMind has held for the past decade. For us, the question is not whether AI accelerates drug discovery. It already does. It is which organisations build the workflows and proprietary data layers that turn that acceleration into a durable competitive position.
More insights
24 July 2026Article
What 400 founder biographies reveal about leadership
In conversation with Sequoia Capital this week, David Senra (who has spent nearly a decade reading a founder biography a week for his Founders podcast, more than 400 in total) was asked to distil everything into a single word.
1 min read
24 July 2026Article
IM8 raises $1 billion, and signals where premium consumer health is heading
This week, IM8 (the AI-native wellness brand co-founded by David Beckham and backed by Prenetics) closed $1 billion in growth financing from General Catalyst's Customer Value Fund.
1 min read
Don’t want to miss what comes next?
Bloom Bites brings the thinking behind our work to your inbox, usually before it turns into an article. One mail, no noise, unsubscribe in a click.
